Information Journal Paper
APA:
Copy. (2020). No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. MEDECINE ET MALADIES INFECTIEUSES, 50(384), 30085-30088. SID. https://sid.ir/paper/771199/en
Vancouver:
Copy. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. MEDECINE ET MALADIES INFECTIEUSES[Internet]. 2020;50(384):30085-30088. Available from: https://sid.ir/paper/771199/en
IEEE:
Copy, “No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection,” MEDECINE ET MALADIES INFECTIEUSES, vol. 50, no. 384, pp. 30085–30088, 2020, [Online]. Available: https://sid.ir/paper/771199/en